KAPRAIMA Trademark
Trademark Overview
On Friday, February 23, 2024, a trademark application was filed for KAPRAIMA with the United States Patent and Trademark Office. The USPTO has given the KAPRAIMA trademark a serial number of 98418315. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 25, 2025. This trademark is owned by Immunocore Limited. The KAPRAIMA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers
General Information
| Serial Number | 98418315 |
| Word Mark | KAPRAIMA |
| Filing Date | Friday, February 23, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, March 25, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 25, 2025 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 23, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Immunocore Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Oxfordshire OX144RY
GB |
| Party Name | Immunocore Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Oxfordshire OX144RY
GB |
Trademark Events
| Event Date | Event Description |
| Friday, February 23, 2024 | NEW APPLICATION ENTERED |
| Monday, July 8, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, September 6, 2024 | ASSIGNED TO EXAMINER |
| Saturday, September 7, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 9, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 9, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 9, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, February 24, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, September 7, 2024 | NON-FINAL ACTION WRITTEN |
| Saturday, September 7, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, January 23, 2025 | ASSIGNED TO EXAMINER |
| Thursday, February 27, 2025 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, March 19, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 25, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 25, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
